Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0357920030370060407
Korean Journal of Pathology
2003 Volume.37 No. 6 p.407 ~ p.412
Prognostic Significance of P53, BCL-2 and PCNA in Diffuse Large B-Cell Lymphoma
Kim Dong-Chul

Lee Ah-Won
Lee Kyo-Young
Kang Chang-Suk
Park Gyeong-Sin
Shim Sang-In
Abstract
Background: Diffuse large B-cell lymphoma (DLBCL) represents a diverse spectrum of clinical presentation, morphologr, and genetic and molecular alterations, and shows variable prognoses and responses to therapy. The lnternational Prognosis Lndex (IPI)is widely used to predict prognosis but is not precise.

Methods: Thirty-nine cases of DLBCL were classifie into low-and high-risk groups according to IPI and were analyzed for their p53, BCL-2,BCL-6 and PCNA expression profile by immunohistochemical staining and overall survival rate.

Results: The mean age of the 39 patients, 23 males and 16 females, was 52.6 years. There were 23 cases (59.0%)in the low-risk group and 16(41.0%)in the high-risk group. p53, BCL-2, BCL-6 and PCNA expression was higher in the high-risk group than in the low-risk group, but only the differences in p53 and BCL-2 expression were statistically significant (p£¼0.05).

Conclusion: The p53 and BCL-2 protein expression in DLBCL may supplement IPI in predicting the prognosis of DLBCL patients.
KEYWORD
Lymphoma, Large Cell, Diffuse, p53, bcl-2, Proliferating Cell Nuclear Antigen
FullTexts / Linksout information
  
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø